CCM
DYN icon

Cinctive Capital Management’s Dyne Therapeutics DYN Stock Holding History

Cinctive Capital Management’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-34,529
Closed -$1.22M – 418
2024
Q2 		$1.22M Buy
+34,529
New +$1M 0.06% 287

Other funds holding DYN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Cinctive Capital Management's DYN Position: Q3 2024 in Review

Cinctive Capital Management sold out of Dyne Therapeutics (DYN) in Q3 2024, closing a stake of 34,529 shares — an estimated $1.22M sold.

Cinctive Capital Management first reported a position in DYN in Q2 2024 and held it in 1 quarter. The position peaked at $1.22M in Q2 2024. 200 funds tracked by Wall St. Rank hold DYN as of Q3 2024.

  • Cinctive Capital Management reported no remaining Dyne Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Cinctive Capital Management sold 34,529 Dyne Therapeutics shares in Q3 2024, an estimated $1.22M.
  • Cinctive Capital Management first reported a position in Dyne Therapeutics in Q2 2024 and held it in 1 quarter.
  • Cinctive Capital Management's Dyne Therapeutics position peaked at $1.22M in Q2 2024.
  • 200 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2024.

Based on Cinctive Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.